Adaptimmune Therapeutics
ADAP
#9324
Rank
โ‚ฌ60.56 M
Marketcap
0,24ย โ‚ฌ
Share price
-20.31%
Change (1 day)
-81.36%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -โ‚ฌ61.86 Million

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.17 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ59.46 Million-41.87%
2023 -โ‚ฌ0.11 Billion-30.65%
2022 -โ‚ฌ0.15 Billion-0.36%
2021 -โ‚ฌ0.15 Billion21.62%
2020 -โ‚ฌ0.13 Billion-4.55%
2019 -โ‚ฌ0.13 Billion69%
2018 -โ‚ฌ75.45 Million-7.47%
2017 -โ‚ฌ81.54 Million24.71%
2016 -โ‚ฌ65.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.15 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.94 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.23 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ0.62 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA